Cellebrite DI [CLBT] vs Microsoft [MSFT] Detailed Stock Comparison

Cellebrite DI Ltd.

NASDAQ
Loading...

Microsoft Corp.

NASDAQ
Loading...

TLDR: Quick Comparison Summary

Based on 21 vital metrics comparison: Cellebrite DI Ltd. wins in 5 metrics, Microsoft Corp. wins in 15 metrics, with 0 ties. Microsoft Corp. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Cellebrite DI Ltd. Microsoft Corp. Better
P/E Ratio (TTM) 42.90 26.56 Microsoft Corp.
Price-to-Book Ratio 6.83 8.06 Cellebrite DI Ltd.
Debt-to-Equity Ratio 4.68 31.54 Cellebrite DI Ltd.
PEG Ratio 3.43 0.44 Microsoft Corp.
EV/EBITDA 37.06 18.16 Microsoft Corp.
Profit Margin (TTM) 16.47% 39.04% Microsoft Corp.
Operating Margin (TTM) 16.15% 47.09% Microsoft Corp.
EBITDA Margin (TTM) 16.15% 47.09% Microsoft Corp.
Return on Equity 19.10% 34.39% Microsoft Corp.
Return on Assets (TTM) 5.10% 14.86% Microsoft Corp.
Free Cash Flow (TTM) $160.32M $71.61B Microsoft Corp.
Dividend Yield N/A 1.11% N/A
1-Year Return -11.69% -2.20% Microsoft Corp.
Price-to-Sales Ratio (TTM) 6.97 10.32 Cellebrite DI Ltd.
Enterprise Value $2.90B $3,183.47B Microsoft Corp.
EV/Revenue Ratio 6.10 10.42 Cellebrite DI Ltd.
Gross Profit Margin (TTM) 84.71% 68.04% Cellebrite DI Ltd.
Revenue per Share (TTM) $2 $41 Microsoft Corp.
Earnings per Share (Diluted) $0.31 $15.97 Microsoft Corp.
Beta (Stock Volatility) 1.28 1.11 Microsoft Corp.
Short % of Float 3.52% 1.09% Microsoft Corp.

Cellebrite DI Ltd. vs Microsoft Corp. Stock Performance Analysis

Loading Price Chart...

CLBT
MSFT

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Cellebrite DI Ltd.-5.34%11.65%3.96%3.20%-21.22%-20.52%
Microsoft Corp.-3.17%3.55%3.32%5.80%-10.55%-9.64%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Cellebrite DI Ltd.-11.69%157.97%48.79%52.48%52.48%52.48%
Microsoft Corp.-2.20%34.24%79.53%769.36%1,783.06%1,878.21%

Performance & Financial Health Analysis: Cellebrite DI Ltd. vs Microsoft Corp.

MetricCLBTMSFT
Market Information
Market Cap i$3.18B$3.09T
Market Cap CategoryMid capMega cap
10 Day Avg. Volume i2,014,39135,949,722
90 Day Avg. Volume i1,712,49432,871,754
Last Close$14.18$427.34
52 Week Range$11.02 - $19.98$356.28 - $555.45
% from 52W High-29.03%-23.06%
All-Time High$26.30 (Feb 03, 2025)$555.45 (Jul 31, 2025)
% from All-Time High-46.08%-23.06%
Growth Metrics
Quarterly Revenue Growth0.18%0.17%
Quarterly Earnings Growth0.10%0.60%
Financial Health
Profit Margin (TTM) i0.16%0.39%
Operating Margin (TTM) i0.16%0.47%
Return on Equity (TTM) i0.19%0.34%
Debt to Equity (MRQ) i4.6831.54
Cash & Liquidity
Book Value per Share (MRQ)$1.95$52.62
Cash per Share (MRQ)$1.75$12.05
Operating Cash Flow (TTM) i$173.54M$160.51B
Levered Free Cash Flow (TTM) i$140.94M$53.64B
Dividends
Last 12-Month Dividend Yield iN/A1.11%
Last 12-Month Dividend iN/A$4.39

Valuation & Enterprise Metrics Analysis: Cellebrite DI Ltd. vs Microsoft Corp.

MetricCLBT (Apr 24, 2026)MSFT (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) i42.9026.56
Forward P/E i21.8022.44
PEG Ratio i3.430.44
Price to Sales (TTM) i6.9710.32
Price to Book (MRQ) i6.838.06
Market Capitalization
Market Capitalization i$3.18B$3.09T
Enterprise Value i$2.90B$3.18T
Enterprise Value Metrics
Enterprise to Revenue i6.1010.42
Enterprise to EBITDA i37.0618.16
Risk & Other Metrics
Beta i1.281.11
Book Value per Share (MRQ) i$1.95$52.62

Financial Statements Comparison: Cellebrite DI Ltd. vs Microsoft Corp.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricCLBT (2025)MSFT (2025)
Revenue/Sales i475.68M281.72B
Cost of Goods Sold i75.17M87.83B
COGS % of Revenue i15.8%31.2%
Gross Profit i400.50M193.89B
Gross Margin i84.2%68.8%
Research & Development i113.88M32.49B
Operating Income (EBIT) i66.48M128.53B
Operating Margin i14.0%45.6%
EBITDA i102.33M160.60B
EBITDA Margin i21.5%57.0%
Pre-Tax Income i90.68M123.63B
Pre-Tax Income % of Revenue i19.1%43.9%
Income Tax i12.35M21.80B
Income Tax % of Revenue i2.6%7.7%
Net Income (Profit) i78.33M101.83B
Profit Margin i16.5%36.1%

Balance Sheet & Liquidity Metrics

MetricCLBT (2025)MSFT (2025)
Cash & Equivalents i124.46M30.24B
Total Current Assets i575.85M191.13B
Total Current Assets % of Revenue i121.1%67.8%
Total Current Liabilities i369.66M141.22B
Total Current Liabilities % of Revenue i77.7%50.1%
Long-Term Debt i18.67M57.59B
Long-Term Debt % of Revenue i3.9%20.4%
Total Shareholders Equity i484.32M343.48B
Retained Earnings i-86.54M237.73B
Retained Earnings % of Revenue i-18.2%84.4%
Property, Plant & Equipment i16.95M24.82B

Cash Flow Statement Comparison

MetricCLBT (2025)MSFT (2025)
Operating Cash Flow i163.74M135.55B
Operating Cash Flow % of Revenue i34.4%48.1%
Capital Expenditures i-13.23M-64.55B
Free Cash Flow i160.32M71.61B
FCF Margin i33.7%25.4%
Debt Repayment iN/A-3.22B
Common Stock Repurchase iN/A-18.42B

Short Interest & Institutional Ownership Analysis

MetricCLBTMSFT
Shares Short i4.91M80.99M
Short Ratio i2.882.51
Short % of Float i3.52%1.09%
Shares Outstanding i248.58M7.43B
Float Shares i122.90M7.41B
% Held by Insiders i43.14%0.08%
% Held by Institutions i53.29%76.12%
% Held by Public i3.57%23.80%

Dividend Analysis & Yield Comparison: Cellebrite DI Ltd. vs Microsoft Corp.

MetricCLBTMSFT
Last 12-Month Dividend iN/A$4.39
Last 12-Month Dividend Yield iN/A1.11%
3-Year Avg Annual Dividend iN/A$3.47
3-Year Avg Dividend Yield iN/A0.20%
3-Year Total Dividends iN/A$10.41
Ex-Dividend DateN/AMay 21, 2026